---

|UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
FORM 10-Q/A
|------------------------------------------------------------------------------------

|[x] | QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- | ---------------------------------------------------------------------------------------

|OR
|--

|[_] | TRANSITION REPORT PURSUANT TO SECTION
13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- | ----------------------------------------------------------------------------------------

|Commission File Number: 1-10768



MEDIWARE INFORMATION SYSTEMS, INC.
 (Exact name of registrant as specified in its charter)
|-----------------------------------------------------------------------------------------------------------------------------

|                                | 
|------------------------------- | 
|New York                        | 
|(State or other jurisdiction of | 
|Incorporation or organization)  | 

|                                         | 
|---------------------------------------- | 
|1121 Old Walt Whitman Road               | 
|Melville, New York                       | 
|(Address of principal executive offices) | 

|(516) 423-7800
 (Registrants telephone number including area code)



(Former name, former address and former fiscal
year, if changes since last report)



Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Sections 12, 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes [X] No
[_]




As of November 1, 1999, there were 6,194,536 shares of Common
Stock, $0.10 par value, of the registrant outstanding.
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|MEDIWARE INFORMATIONS SYSTEMS, INC.



INDEX
|--------------------------------------------

|                                                                     | Page
|-------------------------------------------------------------------- | ----
|PART I              Financial Information                            |     
|                                                                     |     
|ITEM 1.  Financial Statements                                        |     
|Consolidated Balance Sheets as of September 30, 1999                 |     
|(Unaudited) and June 30, 1999 (Audited)                              |     
|                                                                     |     
|Consolidated Statements of Operations                                |     
|For the three months ended September 30, 1999 and 1998 (Unaudited)   |     
|                                                                     |     
|Consolidated Statements of Cash Flows                                |     
|For the three months ended September 30, 1999 and 1998  (Unaudited)  |     
|                                                                     |     
|Notes to Financial Statements                                        |     
|                                                                     |     
|ITEM 2.  Managements Discussion and Analysis of Financial           |     
|Condition and Results of Operations                                  |     
|                                                                     |     
|Year 2000 Compliance                                                 |     
|                                                                     |     
|ITEM 3.  Quantitative and Qualitative Disclosures About Market Risks |     
|                                                                     |     
|PART II              Other Information                               |     
|                                                                     |     
|ITEM 6.  Exhibits and Reports on Form 8-K                            |     
|                                                                     |     
|Signature Page                                                       |     
|                                                                     |     
|Exhibit 11                                                           |     
|                                                                     |     
|Schedule of Computation of Net Income  (Loss) Per Share              |     
|Exhibit 27                                                           |     
|                                                                     |     
|Financial Data Schedule                                              |     

---

|MEDIWARE INFORMATION SYSTEMS, INC. AND SUBSIDIARIES 
CONSOLIDATED BALANCE SHEETS 
(Amounts in thousands, except shares)
|-----------------------------------------------------------------------------------------------------------------------

|                                                                                                                 | September 30,1999 | June 30,1999
|---------------------------------------------------------------------------------------------------------------- | ----------------- | ------------
|
|ASSETS                                                                                                           |                   |             
|Current Assets                                                                                                   |                  
|Cash and cash equivalents                                                                                        |                   | $   4,083   
|Accounts receivable (net of allowance of $750 at September 30, 1999         
 and  $907 at June 30, 1999)        |                   | 7,853       
|Inventories                                                                                                      |                   | 655         
|Prepaid expenses and other current assets                                                                        |                   | 521         
|Deferred tax asset                                                                                               |                   | 448         
|                                                                                                                
|Total current assets                                                                                             |                   | 13,560      
|                                                                                                                
|Fixed assets, net                                                                                                |                   | 1,913       
|Capitalized software costs, net                                                                                  |                   | 4,865       
|Goodwill, net                                                                                                    |                   | 6,181       
|Purchased technology, net                                                                                        |                   | 435         
|Other long-term assets                                                                                           |                   | 132         
|                                                                                                                
|Total Assets                                                                                                     |                   | $ 27,086    
|                                                                                                                
|LIABILITIES AND STOCKHOLDERS EQUITY                                                                             |                  
|Current Liabilities                                                                                              |                  
|Notes payable and current portion of long-term debt                                                              |                   | $   1,043   
|Accounts payable                                                                                                 |                   | 977         
|Advances from customers                                                                                          |                   | 5,679       
|Accrued expenses and other current liabilities                                                                   |                   | 2,739       
|                                                                                                                
|Total current liabilities                                                                                        |                   | 10,438      
|Other long-term liabilities                                                                                      |                   | 206         
|                                                                                                                
|Total liabilities                                                                                                |                   | 10,644      
|                                                                                                                
|Stockholders Equity                                                                                             |                  
|Preferred stock, $.01 par value; authorized 10,000,000                                                           |                  
|shares; none issued or outstanding                                                                               |                   |            
|Common stock, $.10 par value; authorized 12,000,000                                                              |                  
|shares; issued and oustanding, - 6,195,000 shares at September 30, 1999
          and 6,146,000 at June 30, 1999 |                   | 619         
|Additional paid-in capital                                                                                       |                   | 21,581      
|Accumulated deficit                                                                                              |                   | (5,746      
|Unearned compensation                                                                                            |                   | 0           
|Accumulated other comprehensive (loss)                                                                           |                   | (12         
|                                                                                                                
|Total stockholders equity                                                                                       |                   | 16,442      
|                                                                                                                
|Total Liabilities and Stockholders Equity                                                                       |                   | $ 27,086    
|                                                                                                                

|See Notes to Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION SYSTEMS, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME
(Unaudited) 
(Amounts in thousands, except per share amounts)
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|                                                   | Three Months Ended September 30,
|-------------------------------------------------- | --------------------------------
|
|Revenues                                           |                                 
|System sales                                       |                                 
|Services                                           |                                 
|                                                  
|Total revenues                                     |                                 
|                                                  
|Cost and Expenses                                  |                                 
|Cost of systems                                    |                                 
|Cost of services                                   |                                 
|Purchased research and development                 |                                 
|Software development costs                         |                                 
|Selling, general and administrative                |                                 
|                                                  
|Total costs and expenses                           |                                 
|                                                  
|Operating income (loss)                            |                                 
|Interest and other income                          |                                 
|Interest (expense)                                 |                                 
|                                                  
|Earnings (loss)  before provision for income taxes |                                 
|Provision for income taxes                         |                                 
|                                                  
|Net Earnings (Loss)                                |                                 
|                                                  
|Other Comprehensive Income, net of tax             |                                 
|Foreign currency translation adjustment            |                                 
|                                                  
|Comprehensive Income (Loss)                        |                                 
|                                                  
|Earnings (Loss) Per Common Share                   |                                 
|Basic                                              |                                 
|                                                  
|Diluted                                            |                                 
|                                                  
|Weighted Average Common Shares Outstanding         |                                 
|Basic                                              |                                 
|                                                  
|Diluted                                            |                                 
|                                                  

|See Notes to Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION SYSTEMS, INC. AND SUBSIDIARIES 
CONSOLIDATED STATEMENT OF CASH FLOWS
For the Three Months Ended September 30,
 (Amounts in thousands)
|----------------------------------------------------------------------------------------------------------------------------------------------------------

|                                                   | 1999 | 1998     
|-------------------------------------------------- | ---- | ---------
|
|Cash Flows From Operating Activities               |      |          
|Net earnings (loss)                                |      | $    361 
|Adjustments to reconcile net earnings (loss) to    |     
|net cash provided by operating activities:         |     
|Depreciation and amortization                      |      | 543      
|Write-off of acquired research and development     |      |         
|Shares issued to directors                         |      | 25       
|Compensatory stock options                         |      | 11       
|Provision for doubtful accounts                    |      | 35       
|Changes in operating assets and liabilities:       |     
|Accounts receivable                                |      | 473      
|Inventories                                        |      | (252     
|Prepaid and other                                  |      | 41       
|Accounts payable, accrued expenses and             |     
|customer advances                                  |      | 366      
|                                                  
|Net cash provided by operating activities          |      | 1,603    
|                                                  
|Cash Flows From Investing Activities               |     
|Acquisition of fixed assets                        |      | (185     
|Capitalized software costs                         |      | (866     
|Acquisition of Informedics                         |      | 653      
|                                                  
|Net cash used in investing activities              |      | (1,051   
|                                                  
|Cash Flows From Financing Activities               |     
|Repayment of debt                                  |      | (150     
|Proceeds from exercise of options                  |      | 139      
|Other                                              |      | (4       
|                                                  
|Net cash (used in) financing activities            |      | (15      
|                                                  
|Foreign currency translation adjustments           |      | (10      
|                                                  
|Net Increase in Cash and Cash Equivalents          |      | 527      
|Cash and cash equivalents at beginning of year     |      | 3,556    
|                                                  
|Cash and cash equivalents at end of year           |      | $ 4,083  
|                                                  
|Supplemental disclosures of cash flow information: |     
|Cash paid during the period for:                   |     
|Interest                                           |      | $      94
|Income Taxes                                       |      | $    127 

|See Notes to Consolidated Financial Statements.
|-----------------------------------------------

---

|MEDIWARE INFORMATION SYSTEMS, INC., AND SUBSIDIARIES
NOTES TO UNAUDITED FINANICAL STATEMENTS
|--------------------------------------------------------------------------------------------

|1. | FINANICAL STATEMENTS
|-- | --------------------

|In the opinion of management, the accompanying unaudited,
consolidated, condensed financial statements contain all adjustments necessary
to present fairly the financial position of the Company and its results of
operations and cash flows for the interim periods presented. Such financial
statements have been condensed in accordance with the applicable regulations of
the Securities and Exchange Commission (SEC) and therefore, do not
include all disclosures required by generally accepted accounting principles.
These financial statements should be read in conjunction with the Companys audited
financial statements for the year ended June 30, 1999 included in the Companys
annual report filed on Form 10-KSB.


The results of operations for the three months ended September
30, 1999 are not necessarily indicative of the results to be expected for the
entire fiscal year.
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|2. | EARNINGS (LOSS) PER SHARE
|-- | -------------------------

|Basic earnings per share have been computed using the weighted
average number of shares of common stock of the Company (Common Stock)
outstanding for each period presented. For the three months ended September 30,
1999, the dilutive effect of stock options and other common stock equivalents
is included in the calculation of diluted earnings per share using the treasury
stock method. For the three months ended September 30, 1998, common stock
equivalents are not included in the calculation of loss per share as the effect
would be anti-dilutive.
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. | ACQUISITION
|-- | -----------

|In September, 1998, the Company acquired Informedics, Inc. (Informedics)
in exchange for 439,525 shares of the Companys common stock on the basis
of one Company share for each 6.3 shares of Informedics shares. The cost
of the acquisition, which was accounted for as a purchase, aggregated
$7,100,000, including acquisition costs of $801,000, assumed liabilities of
$1,599,000 and $4,700,000 of common stock issued and options assumed (based on
the market price of the Companys common stock in December 1997, when the
acquisition agreement was entered into). Assets acquired aggregated $2,547,000,
including $917,000 of goodwill, $498,000 of technology and $653,000 of cash.
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|4. | SUBSEQUENT EVENTS
|-- | -----------------

|On November 1, 1999, the company announced the purchase of the
LifeTrak(TM) blood bank donor software package developed by Carter BloodCare, and
its intention to market the software on a worldwide basis. LifeTrak(TM) is a
comprehensive system consisting of management systems for Donor, Laboratory and
Distribution and has been used at the Carter BloodCare center for over three
years. The LifeTrak(TM) Lab and Distribution systems are already 510(k) cleared
by the Food and Drug Administration (FDA). The Donor system is awaiting FDA clearance for sales in the United
States.
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS


ForwardLooking Statements


Certain statements made in or incorporated into this 10-Q may
constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, as the same may be amended
from time to time (the Act) and in releases made by the SEC from
time to time. Such forward-looking statements are not based on historical facts
and involve known and unknown risks, uncertainties and other factors which may
cause the actual results of the Company to be materially different from any
future results expressed or implied by such forward-looking statements. These
risks and uncertainties include: (i) fluctuations in quarterly operating
results, (ii) reliance on third party software, (iii) dependence on third party
marketing relationships, (iv) changes in the healthcare industry, (v)
significant competition, (vi) the Companys ability to manage its rapid
growth, (vii) the effects of government regulations on the Company, (viii)
product related liabilities, (ix) risks associated with system errors and
warranties. Amplification of such risks may be found in the Managements
Discussion and Analysis of Financial Condition and Results of Operations section
of the Companys Annual Report on Form 10-KSB for the fiscal year ended
June 30, 1999. The Company does not intend to update publicly any
forward-looking statements.


Results of Operations


Total revenues for the quarter ended September 30, 1999
increased 14.3% or $875,000 from the prior year to $7,003,000. The increase was
positively impacted by a full quarter of operating results for the Informedics Division
acquired in late September of last year and growth in service revenues in all product centers.


System sales decreased by 20.6% or $601,000 from a year ago.
Management believes that system sales were negatively impacted by purchasing
decision delays related to Year 2000 issues.


Service revenues increased by 46.1% and $1,476,000 compared to
last year. The increase was attributable to the contribution of the Informedics product
center, increased levels of implementation activity related to Y2K upgrades,
and implementation of the Companys WORx pharmacy information system, and growth in past contract support in the Hemocare product center.


Cost of systems includes the cost of computer hardware and
sublicensed software purchased from computer and software manufacturers by
Mediware as part of its complete system offering. These costs can vary as the
mix of revenue varies between high margin proprietary software and lower margin
computer hardware and sublicensed software components. Cost of systems was
30.6% of related system sales compared to 30.8% last year. Cost of systems
decreased by 21% or $189,000 from $901,000 in the first quarter of 1998. This
decrease in cost was principally due to the decrease in system sales.


Cost of services includes the salaries of client service
personnel and communications expenses along with the direct expenses. Technical
employees can perform both client services and software development depending
on customer requirements. Thus the costs associated with these technical
employees and the resulting costs of services which are booked will vary from
period to period with customers needs. Cost of services increased by $670,000
to $1,577,000 in the current year and was 33.7% of related revenues compared to
28.3% last year. This
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|increase is primarily related to an increase in implementation
personnel needed to fulfill contract obligations resulting from the increased
sales of systems during the past year and a reallocation of overhead costs to service departments.



Software development costs include salaries, consulting
documentation, office and other expenses incurred in product development along
with amortization of software development costs. Software development costs
increased 69.2% or $459,000 from the same quarter last year. Total expenditures
for software development, including both capitalized and non-capitalized
portions and excluding capitalized software amortization were $1,834,000 as
compared to $991,000 in the first three months of fiscal 1999. Spending on
development has increased among all company divisions. The Company expects to
continue substantial software development expenditures for the foreseeable
future.


Selling, general and administrative expenses include marketing
and sales salaries, commissions, travel and advertising expenses. Also included
are bad debt expenses; legal, accounting and professional fees; salaries and
bonus expense for corporate, divisional, financial and administrative staff;
utilities, rent, communication and other office expenses; and other related
direct administrative expenses. Selling, general and administrative expenses
increased by $437,000 or 16.8% from $2,608,000 in the first three months of
fiscal 1999 to $3,045,000 in the same period in fiscal 2000. This increase in
cost is due to higher communications, travel, administrative, marketing, legal
and professional costs, as well as the addition of the Informedics product
center.


Net interest expense decreased $73,000 or 78.5% in the first
three months of fiscal 2000 versus the same period a year ago. For the three
month period the reduced interest expense is due to the full repayment during
fiscal 1999 of the outstanding balance remaining from the acquisition of the
Pharmakon and JAC divisions of Continental Healthcare Systems, Inc.


The Companys effective tax rate increased to 36% in the
first quarter of fiscal 2000, as compared to 15% in the same quarter in fiscal
1999. The Company's effective tax rate is expected to continue at the same rate through fiscal year 2000.


Net earnings for the quarter increased $4,067,000 or 109.7%,
from a loss of $3,706,000 for the first quarter of fiscal 1999 to a net profit
of $361,000 for the same period in fiscal 2000. Excluding a September 1998
one-time charge for in-process research and development related to the
acquisition of Informedics, net earnings decreased 57.4 percent, from $847,000
in the first quarter of fiscal 1999 to $361,000 for the same period in fiscal
2000.


Liquidity and Capital Resources:


As of September 30, 1999 the Company had cash and cash
equivalents of $4,083,000, an increase of $527,000 from the fiscal year end
June 30, 1999. Net working capital was $3,122,000 and the current ratio was
1.30:1. The Company generated net cash from operations of $1,603,000 and
$608,000 during the three-month period ended September 30, 1999 and 1998,
respectively. The increase in net cash from operations is due primarily to a
decrease in receivables and earnings before non-cash items such as depreciation
and amortization.


The Company invested $1,051,000 and $262,000 during the three
month period ended September 30, 1999 and 1998, respectively, The principal
uses of cash for investing activities during the quarter included purchases of
fixed assets and investments in product development. The purchases were
comprised of equipment and software primarily related to product development
activities. The Company capitalized $866,000 and $519,000 for the quarters ended
September 30, 1999 and 1998, respectively. The investments in product
development were
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

---

|related to continuing new development in the Pharmacy, or, and Blood
Bank divisions. The Company plans to continue enhancing its products and
investing into its next generation information systems.



Cash used in financing activities for the quarter ended
September 30, 1999 and 1998, related primarily to the repayment of debt. During
the current quarter the Company repaid notes payable to a director in the
amount of $100,000, and a non-affiliate in the amount of $50,000.


The recent acquisition of the LifeTrack(TM) blood bank donor software package from Carter
BloodCare will be financed by current cash reserves as well as funds generated by operations.




Exclusive of activities involving any future acquisitions of products or
companies that compliment or augment the existing line of products, management
believes that existing funds and cash generated from operations will be
sufficient to meet operating requirements for the remainder of fiscal year
2000. The Companys liquidity is influenced by the Companys ability
to perform in a competitive industry that is currently impacted by Year 2000
readiness concerns and the related deferral of system purchases and implementations of systems.
The factors that may affect liquidity are the ability to maintain or reduce the length of
the sales cycle, and the ability to collect
cash from clients as implementations of systems progresses.


Year 2000 Compliance


A discussion of the Companys Year 2000 compliance may be
found in the Managements Discussion and Analysis of Financial Condition
and Results of Operations in the Companys Annual Report on Form 10-KSB
for the fiscal year ended June 30, 1999.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISKS


For a discussion of quantitative and qualitative disclosures
about market risks, please see the Managements Discussion and Analysis of
Financial Condition and Results of Operations section of the Companys
Annual Report on Form 10-KSB for the fiscal year ended June 30, 1999.



PART II OTHER INFORMATION


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|(a). | Exhibits
|---- | --------

|Exhibit 11. Schedule of Computation of Net Income (Loss) Per
Share
|------------------------------------------------------------------

|(b). | Reports on Form 8-K
|---- | -------------------

|No reports on Form 8-K were filed by the Company during the
quarter ended September 30, 1999.
|---------------------------------------------------------------------------------------------

---

|SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | MEDIWARE INFORMATION SYSTEMS, INC.(Registrant)
| | ----------------------------------------------

|                               |                                                                      
|------------------------------ | ---------------------------------------------------------------------
|                               |                                                                      
|Date:  December 15, 1999(Date) | /s/ Kerry RobisonKerry Robison
Chief Financial and Accounting Officer